In reply to Schäfer et al: New evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma

Anna Russignan, Cecilia Spina, Nicola Tamassia, Adriana Cassaro, Antonella Rigo, Anna Bagnato, Laura Rosanò, Angela Bonalumi, Michele Gottardi, Lucia Zanatta, Alice Giacomazzi, Maria T. Scupoli, Martina Tinelli, Ugo Salvadori, Federico Mosna, Alberto Zamò, Marco A. Cassatella, Fabrizio Vinante, Cristina Tecchio

Research output: Contribution to journalArticle

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusAccepted/In press - Jan 1 2018

Keywords

  • Bortezomib
  • Bosentan
  • Endothelin 1 axis
  • Macitentan
  • Multiple myeloma

ASJC Scopus subject areas

  • Hematology

Cite this

Russignan, A., Spina, C., Tamassia, N., Cassaro, A., Rigo, A., Bagnato, A., Rosanò, L., Bonalumi, A., Gottardi, M., Zanatta, L., Giacomazzi, A., Scupoli, M. T., Tinelli, M., Salvadori, U., Mosna, F., Zamò, A., Cassatella, M. A., Vinante, F., & Tecchio, C. (Accepted/In press). In reply to Schäfer et al: New evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma. British Journal of Haematology. https://doi.org/10.1111/bjh.15240